Finding reliable biomarkers is difficult due to the noise and variability in omics data across diverse cell types.

By dissecting cellular networks at the cell-type level, Cell Blueprint helps in identifying consistent and robust biomarkers specific to particular cell types, improving diagnostic accuracy.

Drug repurposing efforts often fail due to a lack of understanding of drug effects on specific cell types, leading to off-target effects and inefficacy. 

Cell Blueprint allows for the evaluation of drug impacts on cell-type-specific networks, enhancing the prediction of successful drug repurposing candidates by considering their effects on the relevant cell types.

Unraveling the mechanisms underlying complex diseases is complicated by the interaction of multiple cell types and pathways.

Cell Blueprint provides insights into how disease-associated networks differ across cell types, helping to pinpoint the cellular mechanisms driving disease and identify potential therapeutic interventions.